Cost-Sharing for Specialty Drugs PDF, 71.17 KB
Cost-saving opportunities among hospitalized patients with acute
Cost-efficient service provision in neurorehabilitation: defining
Cost-Effectiveness Strategies, Part 3 of 4
Cost-Effectiveness of Two Screening Programs for Microalbuminuria
Cost-effectiveness of the promotion of physical activity in health care
Cost-effectiveness of Mental Health Interventions in Estonia
Cost-effectiveness of initial stress cardiovascular MR
Cost-effectiveness of Ikervis® in severe dry eye disease in the UK
Cost-effectiveness of disease management programs in COPD
Cost-Effectiveness of CT Screening in the National Lung Screening
Cost-Effectiveness of Catheter Ablation Treatment for Patients with
Cost-Effectiveness Of Bevacizumab Concomitant With The Standard
Cost-effectiveness of alendronate in the treatment of low bone
Cost-Effectiveness Analysis Overview Summary & COURAGE Case
Cost-effectiveness analysis of the first-line therapies for
Cost-Analysis of Prophylactic Antibiotics in Spontaneous Bacterial
Cost Utility Analysis of Vagal Nerve Stimulators
Cost Savings of Reduced Constipation Rates Attributed to Increased
Cost of disorders of the brain in Europe 2010
